Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in
chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled …

Inhaled bronchodilator therapy with long-acting muscarinic antagonists (LAMAs) and long-
acting β2-agonists (LABAs) in combination is currently the mainstay of treatment for chronic …

Introducción: La enfermedad pulmonar obstructiva crónica (EPOC) es una de las principales
causas de muerte en México y en el mundo. Pese a que en los últimos años se ha …

Although pharmacological treatment of COPD is codified in different guidelines and strategy
documents, there is abundant evidence of discrepancy between what they suggest and what …

The right treatment for the right patient with COPD: lessons from the IMPACT trial |
European Respiratory Society Skip to main content Main menu Home Current issue ERJ …

Purpose: This real-world study evaluated the effectiveness of different inhalation therapies in
patients with symptomatic chronic obstructive pulmonary disease (COPD) in China and also …

ABSTRACT Introduction The Global Initiative for Chronic Obstructive Lung Disease (GOLD)
strategy report provides guidance on effective management of chronic obstructive …

This real-world study compared the effectiveness of triple therapy (TT; long-acting
muscarinic antagonists (LAMAs)/long-acting inhaled β-agonists (LABAs)/inhaled …

BACKGROUND: The 2018 Global Initiative for Chronic Obstructive Lung Disease (GOLD)
recommends combination long-acting muscarinic antagonists/long-acting beta2-agonists …

Purpose This study aimed to describe the real-world treatment of German incident COPD
patients, compare that treatment with clinical guidelines, and provide insight into disease …